1.
Tirkes T1,
Sandrasegaran K,
Patel AA,
Hollar MA,
Tejada JG,
Tann M,
Akisik FM,
Lappas JC.
Peritoneal and retroperitoneal anatomy and its relevance for cross-sectional imaging.
Radiographics.
2012 Mar-Apr;32(2):437-51.
2.
Patel CM1,
Sahdev A,
Reznek RH.
CT,
MRI and PET imaging in peritoneal malignancy. Cancer Imaging.
2011 Aug 24;11:123-39.
3.
Diop AD1,
Fontarensky M1,
Montoriol PF1,
Da Ines D2.
CT imaging of peritoneal carcinomatosis and its mimics.
Diagn Interv Imaging.
2014 Sep;95(9):861-72.
4.
Kyriazi S,
Kaye SB,
deSouza NM.
Imaging ovarian cancer and peritoneal metastases – current and emerging techniques. Nat Rev Clin Oncol.
2010 Jul;7(7):381-93.
5.
Ognong-Boulemo A1,2,
Dohan A3,
Hoeffel C4,
Stanek A5,
Golfier F1,6,7,
Glehen O1,6,8,
Valette PJ1,2,6,
Rousset P9,10,11 Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI. Abdom Radiol(NY).2017 Jul;42(7):1975-1992.
6.
Aherne EA1,
Fenlon HM1,
Shields CJ2,
Mulsow JJ2,
Cronin CG1.
What the Radiologist Should Know About Treatment of Peritoneal Malignancy.
AJR Am J Roentgenol.
2017 Mar;208(3):531-543.
7.
Dohan A1,2,
Hoeffel C3,
Soyer P1,
Jannot AS4,
Valette PJ5,
Thivolet A5,
Passot G6,
Glehen O6,
Rousset P.5 Evaluation of the peritoneal carcinomatosis index with CT and MRI. Br J Surg.
2017 Aug;104(9):1244-1249.
8.
Laghi A1,
Bellini D2,
Rengo M2,
Accarpio F3,
Caruso D2,
Biacchi D3,
Di Giorgio A3,
Sammartino P3.
Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. Radiol Med.
2017 Jan;122(1):1-15.
9.
Low RN1,
Barone RM,
Lucero J.
Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol.
2015 May;22(5):1708-15.
10.
Mohkam K1,2,
Passot G1,2,
Cotte E1,2,
Bakrin N1,2,
Gilly FN1,2,
Ledochowski S3,
Bernard L4,
Valette PJ2,5,
Glehen O6,7,
Rousset P2,5 Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery.
Ann Surg Oncol.
2016 Apr;23(4):1261-70.
11.
Dohan A1,
Hobeika C2,
Najah H2,
Pocard M3,
Rousset P4,
Eveno C5.
Preoperative assessment of peritoneal carcinomatosis of colorectal origin.
J ViscSurg.2018Sep;155(4):293-303.
12.
Verwaal VJ,
van Tinteren H,
van Ruth S,
et al.
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004;91:739–46.
13.
Jacquet P,
Sugarbaker PH.
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.
Cancer Treat Res 1996;82:359-74.
14.
Brun JL,
Rouzier R,
Uzan S,
Daraï E.
External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol 2008,
110(3):354–59.
15.
Fagotti A,
Ferrandina G,
Fanfani F,
et al.
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 2008 Dec;199(6):642.e1-6.
16.
Gilly FN,
Carry PY,
Sayag AC,
et al.
Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis.
Hepatogastroenterology 1994;41:124–9.
17.
Chandramohan A1,
Thrower A2,
Smith SA2,
Shah N2,
Moran B3.
"PAUSE": a method for communicating the radiological extent of peritoneal malignancy.ClinRadiol.2017Nov;72(11):972-980.
18.
Nougaret S1,
Addley HC,
Colombo PE,
Fujii S,
Al Sharif SS,
Tirumani SH,
Jardon K,
Sala E,
Reinhold C.
Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics.
2012 Oct;32(6):1775-800; discussion 1800-3.